Browsing by Author Rutkowski, Piotr

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2017Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trialLong, Georgina; Arance, A; Ascierto, Paolo A; Del Vecchio, M; Di Giacomo, A; Dummer, R; Dutriaux, Caroline; et al, Various; Gutzmer, R.; Rutkowski, Piotr; Schadendorf, D; Northern Clinical School: MedicineBinimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial, The Lancet Oncology, vol.18, 4, 2017,pp 435-445
2016Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III checkmate 066 studyLong, Georgina; Abernethy, Amy P; Ascierto, Paolo; Atkinson, V; Coon, C.; Dastani, I; Gilloteau, I; Hassel, Jessica; Robert, Caroline; Rutkowski, Piotr; Savage, Kerry; Taylor, F.; Waxman, I M; Northern Clinical School: MedicineEffect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III checkmate 066 study, Annals of Oncology, vol.27, 10, 2016,pp 1940-1946
2017Health-related quality of life results from the phase III CheckMate 067 studyLong, Georgina; Chiarion-Sileni, Vanna; Cowey, C; et al, Various; Gonzalez, R; Grob, Jean-Jacques; Hodi, F. Stephen; Larkin, James; Rutkowski, Piotr; Schadendorf, Dirk; Wolchok, Jedd D.; Northern Clinical School: MedicineHealth-related quality of life results from the phase III CheckMate 067 study, European Journal of Cancer, vol.82, N/A, 2017,pp 80-91
2015Improved overall survival in melanoma with combined dabrafenib and trametinibLong, Georgina; Chiarion-Sileni, Vanna; Dummer, R; et al, Various; Grange, Florent; Karaszewska, Boguslawa; Lichinitser, Michael; Mackiewicz, Andrzej; Mortier, Laurent; Robert, Caroline; Rutkowski, Piotr; Schachter, Jacob; Stroiakovski, Daniel; Central Clinical School: The Sydney Cancer CentreImproved overall survival in melanoma with combined dabrafenib and trametinib, New England Journal of Medicine, vol.372, 1, 2015,pp 30-39
2012Improved Survival with MEK Inhibition in BRAF-Mutated MelanomaHersey, Peter; Demidov, Lev; Drummer, Reinhard; et al, Various; Flaherty, Keith; Garbe, Claus; Hassel, Jessica; Milhem, Mohammed; Mohr, P; Nathan, Paul; Robert, Caroline; Rutkowski, Piotr; Northern Clinical School: SurgeryImproved Survival with MEK Inhibition in BRAF-Mutated Melanoma, New England Journal of Medicine, vol.367, 2, 2012,pp 107-114
2017Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trialMcNeil, Catriona; Arance, A; Ascierto, Paolo A; Bastholt, Lars; Chiarion-Sileni, Vanna; Del Vecchio, Michele; et al, Various; Hamid, Omid; Lebbe, Celeste; Mackiewicz, Andrzej; Robert, Caroline; Rutkowski, Piotr; Central Clinical School: MedicineIpilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial, The Lancet Oncology, vol.18, 5, 2017,pp 611-622
2015Nivolumab in Previously Untreated Melanoma without BRAF MutationLong, Georgina; Brady, Ben; Dutriaux, Caroline; et al, Various; Hassel, Jessica; Hernberg, Micaela; Kalinka-Warzocha, Ewa; Maio, Michele; McNeil, Catriona; Mortier, Laurent; Robert, Caroline; Rutkowski, Piotr; Savage, Kerry; Central Clinical School: The Sydney Cancer CentreNivolumab in Previously Untreated Melanoma without BRAF Mutation, The New England Journal of Medicine, vol.372, 4, 2015,pp 320-330
2017Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaCarlino, Matteo; Long, Georgina; Chiarion-Sileni, Vanna; Cowey, C; et al, Various; Gonzalez, Rene; Grob, Jean-Jacques; Lao, Christopher; Rutkowski, Piotr; Schadendorf, Dirk; Wagstaff, John; Wolchok, Jedd D.; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineOverall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma, New England Journal of Medicine, vol.377, 14, 2017,pp 1345-1356
2015Treatment algorithms in stage IV melanomaKefford, Richard (Rick); Dummer, R; Eggermont, Alexander; Espinosa, E; Gogas, Helen; Grob, Jean-Jacques; Hauschild, Axel; Martin-Algarra, Salvador; Robert, C; Rutkowski, Piotr; Schadendorf, D; Western Clinical School: Westmead Institute for Medical ResTreatment algorithms in stage IV melanoma, American Journal of Therapeutics, vol.22, 1, 2015,pp 61-67